Literature DB >> 12954070

Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.

Johannes Schütz1, Mariana Spetea, Martin Koch, Mario D Aceto, Louis S Harris, Andrew Coop, Helmut Schmidhammer.   

Abstract

The synthesis and the biological and pharmacological evaluation of several 14-phenylpropoxy analogues of 14-methoxymetopon are described. Most of the new compounds were nonselective and exhibited binding affinities in the subnanomolar or low nanomolar range at opioid receptors mu, kappa, delta), with 14-phenylpropoxymetopon (PPOM; 7) displaying the highest affinity for all three opioid receptor types. The most striking finding of this study is that the derivatives from the novel series of N-methyl-14-phenylpropoxymorphinans acted as extremely powerful antinociceptives with potencies higher than that of 14-methoxymetopon (1) and even etorphine. 14-Phenylpropoxymetopon (PPOM; 7) showed considerably increased potency in the in vivo assays in mice (25-fold in the tail-flick assay, 10-fold in the hot-plate assay, and 2.5-fold in the paraphenylquinone writhing test) when compared to etorphine, while it was equipotent to dihydroetorphine in the hot-plate assay and the paraphenylquinone writhing test and ca. twice as potent in the tail-flick assay than this reference compound. The 3-O-alkyl ethers of PPOM, compounds 6 and 8, showed less potency in in vivo assays, but partly surpassed the potency of the 3-OH analogue 14-methoxymetopon (1).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954070     DOI: 10.1021/jm030878b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Consensus 3D model of μ-opioid receptor ligand efficacy based on a quantitative Conformationally Sampled Pharmacophore.

Authors:  Jihyun Shim; Andrew Coop; Alexander D MacKerell
Journal:  J Phys Chem B       Date:  2011-05-12       Impact factor: 2.991

Review 2.  Most recent developments and modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan derivatives.

Authors:  L Stavitskaya; A Coop
Journal:  Mini Rev Med Chem       Date:  2011-10       Impact factor: 3.862

3.  Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors.

Authors:  Lidiya Stavitskaya; Jihyun Shim; Jason R Healy; Rae R Matsumoto; Alexander D MacKerell; Andrew Coop
Journal:  Bioorg Med Chem       Date:  2012-05-11       Impact factor: 3.641

4.  In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function.

Authors:  Mariana Spetea; Catalina R Bohotin; Muhammad F Asim; Kurt Stübegger; Helmut Schmidhammer
Journal:  Eur J Pharm Sci       Date:  2010-06-18       Impact factor: 4.384

5.  Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods.

Authors:  Jianxin Cheng; Guixia Liu; Jing Zhang; Zhejun Xu; Yun Tang
Journal:  J Mol Model       Date:  2010-05-25       Impact factor: 1.810

6.  Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies.

Authors:  Mariana Spetea; Petra Windisch; Yan Guo; Indre Bileviciute-Ljungar; Johannes Schütz; Muhammad Faheem Asim; Ilona P Berzetei-Gurske; Pal Riba; Kornel Kiraly; Susanna Fürst; Mahmoud Al-Khrasani; Helmut Schmidhammer
Journal:  J Med Chem       Date:  2011-01-14       Impact factor: 7.446

Review 7.  Development of 5-Substituted N-Methylmorphinan-6-ones as Potent Opioid Analgesics with Improved Side-Effect Profile.

Authors:  Helmut Schmidhammer; Mariana Spetea
Journal:  Int J Med Chem       Date:  2012-06-17

8.  Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.

Authors:  Stefan M Noha; Helmut Schmidhammer; Mariana Spetea
Journal:  ACS Chem Neurosci       Date:  2017-02-09       Impact factor: 4.418

9.  14-Methoxymetopon, a highly potent mu opioid agonist, biphasically affects ethanol intake in Sardinian alcohol-preferring rats.

Authors:  Valentina Sabino; Pietro Cottone; Luca Steardo; Helmut Schmidhammer; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2007-03-08       Impact factor: 4.415

10.  Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor.

Authors:  Tanila Ben Haddou; Davide Malfacini; Girolamo Calo; Mario D Aceto; Louis S Harris; John R Traynor; Andrew Coop; Helmut Schmidhammer; Mariana Spetea
Journal:  Mol Pain       Date:  2014-07-24       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.